Antisense modulation of damage-specific DNA binding protein 1, p127 expression
AssigneeIsis Pharmaceuticals, Inc.
InventorsIan Popoff, Jacqueline Wyatt
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of Damage-specific DNA binding protein 1, p127. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Damage-specific DNA binding protein 1, p127. Methods of using these compounds for modulation of Damage-specific DNA binding protein 1, p127 expression and for treatment of diseases associated with expression of Damage-specific DNA binding protein 1, p127 are provided.
Claims19
An oligomeric compound up to 50 nucleobases in length comprising SEQ ID NO:73, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.